Top Markets
Coin of the day
Fresh Tracks Therapeutics, Inc. Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics, Inc.

FRTX
Peringkat dalam Saham #36397
Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused... Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused on creating diverse prescription therapies to address a range of severe autoimmune, inflammatory, and other chronic debilitating conditions, primarily within the U.S. market. A key compound in its development pipeline is sofpironium bromide, which has successfully completed Phase III clinical trials for the management of primary axillary hyperhidrosis. The company is also advancing BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent STING pathway inhibitor with potential for treating autoinflammatory and rare genetic disorders. Furthermore, Fresh Tracks is engaged in developing next-generation kinase inhibitors. The company maintains crucial licensing and collaborative partnerships, including agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. (and Dr. Nicholas S. Bodor), and AnGes, Inc. Founded in 2009 and based in Boulder, Colorado, the organization rebranded in September 2022, previously operating under the name Brickell Biotech, Inc.
Harga Saham
$0.94
Terakhir disinkronkan: 2025-02-28
Kapitalisasi Pasar
$2.73M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Fresh Tracks Therapeutics, Inc. (FRTX)

Kategori

Pendapatan untuk Fresh Tracks Therapeutics, Inc. (FRTX)
Pendapatan pada Dec 2023 TTM: $8.01M
Menurut laporan keuangan terbaru dari Fresh Tracks Therapeutics, Inc., pendapatan saat ini (TTM) adalah $8.01M. Pada tahun 2022, perusahaan menghasilkan pendapatan sebesar $6.94M peningkatan dibandingkan pendapatan pada tahun 2021 yang sebesar $404.00K. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Fresh Tracks Therapeutics, Inc. dari 2000 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Mengubah
2026 (TTM) $8.01M 0.00%
2023 $8.01M 15.31%
2022 $6.94M 1,618.56%
2021 $404.00K -77.83%
2020 $1.82M -76.99%
2019 $7.92M 388.10%
2018 $1.62M -88.26%
2017 $13.82M -4.90%
2016 $14.53M -30.64%
2015 $20.95M 37.67%
2014 $15.22M 97.16%
2013 $7.72M -55.94%
2012 $17.52M -41.64%
2011 $30.02M 244.60%
2010 $8.71M -31.33%
2009 $12.69M 59.45%
2008 $7.96M 44.34%
2007 $5.51M -62.61%
2006 $14.74M 22.80%
2005 $12.00M -17.48%
2004 $14.55M 80.05%
2003 $8.08M 15.29%
2002 $7.01M -38.35%
2001 $11.37M 49.16%
2000 $7.62M 0.00%
Pendapatan untuk perusahaan serupa atau pesaing
Perusahaan Pendapatan Perbedaan Pendapatan Negara
$12.62B 157,585.49%
US
$6.02B 75,109.68%
NL
- -
CH
- -
KR
$10.11B 126,190.12%
BE